IBDEI0HZ ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18087,0)
 ;;=A52.9^^81^946^234
 ;;^UTILITY(U,$J,358.3,18087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18087,1,3,0)
 ;;=3^Syphilis,Tertiary
 ;;^UTILITY(U,$J,358.3,18087,1,4,0)
 ;;=4^A52.9
 ;;^UTILITY(U,$J,358.3,18087,2)
 ;;=^5000308
 ;;^UTILITY(U,$J,358.3,18088,0)
 ;;=A52.3^^81^946^233
 ;;^UTILITY(U,$J,358.3,18088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18088,1,3,0)
 ;;=3^Syphilis,Neurosyphilis
 ;;^UTILITY(U,$J,358.3,18088,1,4,0)
 ;;=4^A52.3
 ;;^UTILITY(U,$J,358.3,18088,2)
 ;;=^5000298
 ;;^UTILITY(U,$J,358.3,18089,0)
 ;;=J03.90^^81^946^236
 ;;^UTILITY(U,$J,358.3,18089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18089,1,3,0)
 ;;=3^Tonsillitis, acute, unspecified
 ;;^UTILITY(U,$J,358.3,18089,1,4,0)
 ;;=4^J03.90
 ;;^UTILITY(U,$J,358.3,18089,2)
 ;;=^5008135
 ;;^UTILITY(U,$J,358.3,18090,0)
 ;;=A15.0^^81^946^240
 ;;^UTILITY(U,$J,358.3,18090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18090,1,3,0)
 ;;=3^Tuberculosis, pulmonary
 ;;^UTILITY(U,$J,358.3,18090,1,4,0)
 ;;=4^A15.0
 ;;^UTILITY(U,$J,358.3,18090,2)
 ;;=^5000062
 ;;^UTILITY(U,$J,358.3,18091,0)
 ;;=R76.11^^81^946^239
 ;;^UTILITY(U,$J,358.3,18091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18091,1,3,0)
 ;;=3^Tuberculosis, latent
 ;;^UTILITY(U,$J,358.3,18091,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,18091,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,18092,0)
 ;;=A15.8^^81^946^238
 ;;^UTILITY(U,$J,358.3,18092,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18092,1,3,0)
 ;;=3^Tuberculosis NEC
 ;;^UTILITY(U,$J,358.3,18092,1,4,0)
 ;;=4^A15.8
 ;;^UTILITY(U,$J,358.3,18092,2)
 ;;=^266093
 ;;^UTILITY(U,$J,358.3,18093,0)
 ;;=J06.9^^81^946^241
 ;;^UTILITY(U,$J,358.3,18093,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18093,1,3,0)
 ;;=3^URI/Cold Symptoms
 ;;^UTILITY(U,$J,358.3,18093,1,4,0)
 ;;=4^J06.9
 ;;^UTILITY(U,$J,358.3,18093,2)
 ;;=^5008143
 ;;^UTILITY(U,$J,358.3,18094,0)
 ;;=N34.2^^81^946^243
 ;;^UTILITY(U,$J,358.3,18094,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18094,1,3,0)
 ;;=3^Urethritis
 ;;^UTILITY(U,$J,358.3,18094,1,4,0)
 ;;=4^N34.2
 ;;^UTILITY(U,$J,358.3,18094,2)
 ;;=^88231
 ;;^UTILITY(U,$J,358.3,18095,0)
 ;;=R63.4^^81^946^246
 ;;^UTILITY(U,$J,358.3,18095,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18095,1,3,0)
 ;;=3^Weight Loss
 ;;^UTILITY(U,$J,358.3,18095,1,4,0)
 ;;=4^R63.4
 ;;^UTILITY(U,$J,358.3,18095,2)
 ;;=^5019542
 ;;^UTILITY(U,$J,358.3,18096,0)
 ;;=N39.0^^81^946^242
 ;;^UTILITY(U,$J,358.3,18096,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18096,1,3,0)
 ;;=3^UTI
 ;;^UTILITY(U,$J,358.3,18096,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,18096,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,18097,0)
 ;;=N30.90^^81^946^56
 ;;^UTILITY(U,$J,358.3,18097,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18097,1,3,0)
 ;;=3^Cystitis w/o hematuria
 ;;^UTILITY(U,$J,358.3,18097,1,4,0)
 ;;=4^N30.90
 ;;^UTILITY(U,$J,358.3,18097,2)
 ;;=^5015642
 ;;^UTILITY(U,$J,358.3,18098,0)
 ;;=N76.0^^81^946^244
 ;;^UTILITY(U,$J,358.3,18098,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18098,1,3,0)
 ;;=3^Vaginitis, Unspecified cause, acute
 ;;^UTILITY(U,$J,358.3,18098,1,4,0)
 ;;=4^N76.0
 ;;^UTILITY(U,$J,358.3,18098,2)
 ;;=^5015826
 ;;^UTILITY(U,$J,358.3,18099,0)
 ;;=N76.2^^81^946^17
 ;;^UTILITY(U,$J,358.3,18099,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18099,1,3,0)
 ;;=3^Acute vulvitis
 ;;^UTILITY(U,$J,358.3,18099,1,4,0)
 ;;=4^N76.2
 ;;^UTILITY(U,$J,358.3,18099,2)
 ;;=^5015828
 ;;^UTILITY(U,$J,358.3,18100,0)
 ;;=N76.3^^81^946^227
 ;;^UTILITY(U,$J,358.3,18100,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18100,1,3,0)
 ;;=3^Subacute and chronic vulvitis
 ;;^UTILITY(U,$J,358.3,18100,1,4,0)
 ;;=4^N76.3
 ;;^UTILITY(U,$J,358.3,18100,2)
 ;;=^5015829
 ;;^UTILITY(U,$J,358.3,18101,0)
 ;;=N76.1^^81^946^226
 ;;^UTILITY(U,$J,358.3,18101,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18101,1,3,0)
 ;;=3^Subacute and chronic vaginitis
 ;;^UTILITY(U,$J,358.3,18101,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,18101,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,18102,0)
 ;;=B97.89^^81^946^245
 ;;^UTILITY(U,$J,358.3,18102,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18102,1,3,0)
 ;;=3^Viral syndrome
 ;;^UTILITY(U,$J,358.3,18102,1,4,0)
 ;;=4^B97.89
 ;;^UTILITY(U,$J,358.3,18102,2)
 ;;=^5000879
 ;;^UTILITY(U,$J,358.3,18103,0)
 ;;=Z77.21^^81^946^85
 ;;^UTILITY(U,$J,358.3,18103,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18103,1,3,0)
 ;;=3^Exposure to potentially hazardous bodily fluids
 ;;^UTILITY(U,$J,358.3,18103,1,4,0)
 ;;=4^Z77.21
 ;;^UTILITY(U,$J,358.3,18103,2)
 ;;=^5063323
 ;;^UTILITY(U,$J,358.3,18104,0)
 ;;=Z72.51^^81^946^121
 ;;^UTILITY(U,$J,358.3,18104,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18104,1,3,0)
 ;;=3^High Risk Sexual Behaviors
 ;;^UTILITY(U,$J,358.3,18104,1,4,0)
 ;;=4^Z72.51
 ;;^UTILITY(U,$J,358.3,18104,2)
 ;;=^5063258
 ;;^UTILITY(U,$J,358.3,18105,0)
 ;;=Z20.828^^81^946^48
 ;;^UTILITY(U,$J,358.3,18105,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18105,1,3,0)
 ;;=3^Contact or exposure to other viral diseases
 ;;^UTILITY(U,$J,358.3,18105,1,4,0)
 ;;=4^Z20.828
 ;;^UTILITY(U,$J,358.3,18105,2)
 ;;=^5062774
 ;;^UTILITY(U,$J,358.3,18106,0)
 ;;=Z79.899^^81^946^147
 ;;^UTILITY(U,$J,358.3,18106,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18106,1,3,0)
 ;;=3^Long term use of medications
 ;;^UTILITY(U,$J,358.3,18106,1,4,0)
 ;;=4^Z79.899
 ;;^UTILITY(U,$J,358.3,18106,2)
 ;;=^5063343
 ;;^UTILITY(U,$J,358.3,18107,0)
 ;;=Z23.^^81^946^75
 ;;^UTILITY(U,$J,358.3,18107,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18107,1,3,0)
 ;;=3^Encounter for immunization
 ;;^UTILITY(U,$J,358.3,18107,1,4,0)
 ;;=4^Z23.
 ;;^UTILITY(U,$J,358.3,18107,2)
 ;;=^5062795
 ;;^UTILITY(U,$J,358.3,18108,0)
 ;;=A08.4^^81^946^97
 ;;^UTILITY(U,$J,358.3,18108,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18108,1,3,0)
 ;;=3^Gastroenteritis, viral
 ;;^UTILITY(U,$J,358.3,18108,1,4,0)
 ;;=4^A08.4
 ;;^UTILITY(U,$J,358.3,18108,2)
 ;;=^5000059
 ;;^UTILITY(U,$J,358.3,18109,0)
 ;;=B16.9^^81^946^106
 ;;^UTILITY(U,$J,358.3,18109,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18109,1,3,0)
 ;;=3^Hepatitis B, acute
 ;;^UTILITY(U,$J,358.3,18109,1,4,0)
 ;;=4^B16.9
 ;;^UTILITY(U,$J,358.3,18109,2)
 ;;=^5000540
 ;;^UTILITY(U,$J,358.3,18110,0)
 ;;=B18.1^^81^946^107
 ;;^UTILITY(U,$J,358.3,18110,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18110,1,3,0)
 ;;=3^Hepatitis B, chronic without coma
 ;;^UTILITY(U,$J,358.3,18110,1,4,0)
 ;;=4^B18.1
 ;;^UTILITY(U,$J,358.3,18110,2)
 ;;=^5000547
 ;;^UTILITY(U,$J,358.3,18111,0)
 ;;=B17.10^^81^946^109
 ;;^UTILITY(U,$J,358.3,18111,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18111,1,3,0)
 ;;=3^Hepatitis C, acute
 ;;^UTILITY(U,$J,358.3,18111,1,4,0)
 ;;=4^B17.10
 ;;^UTILITY(U,$J,358.3,18111,2)
 ;;=^5000542
 ;;^UTILITY(U,$J,358.3,18112,0)
 ;;=B18.2^^81^946^110
 ;;^UTILITY(U,$J,358.3,18112,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18112,1,3,0)
 ;;=3^Hepatitis C, chronic without coma
 ;;^UTILITY(U,$J,358.3,18112,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,18112,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,18113,0)
 ;;=J11.1^^81^946^129
 ;;^UTILITY(U,$J,358.3,18113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18113,1,3,0)
 ;;=3^Influenza
 ;;^UTILITY(U,$J,358.3,18113,1,4,0)
 ;;=4^J11.1
 ;;^UTILITY(U,$J,358.3,18113,2)
 ;;=^5008158
 ;;^UTILITY(U,$J,358.3,18114,0)
 ;;=A92.30^^81^946^247
 ;;^UTILITY(U,$J,358.3,18114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18114,1,3,0)
 ;;=3^West Nile
 ;;^UTILITY(U,$J,358.3,18114,1,4,0)
 ;;=4^A92.30
 ;;^UTILITY(U,$J,358.3,18114,2)
 ;;=^5000443
 ;;^UTILITY(U,$J,358.3,18115,0)
 ;;=A49.8^^81^946^13
 ;;^UTILITY(U,$J,358.3,18115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18115,1,3,0)
 ;;=3^Acinetobacter
 ;;^UTILITY(U,$J,358.3,18115,1,4,0)
 ;;=4^A49.8
 ;;^UTILITY(U,$J,358.3,18115,2)
 ;;=^5000240
 ;;^UTILITY(U,$J,358.3,18116,0)
 ;;=A74.9^^81^946^41
 ;;^UTILITY(U,$J,358.3,18116,1,0)
 ;;=^358.31IA^4^2
